Key result
The prevalence of peripheral arterial disease in hypertensive patients was 14.4%, and was significantly lower in those achieving their blood pressure target (9.6% vs. 16.8%; P<0.001).
Why the study?
What is the prevalence of peripheral arterial disease (PAD) assessed by ankle-brachial index in hypertensive patients?
Cross-Sectional (n=21,892)
Yes
What is the prevalence of peripheral arterial disease (PAD) assessed by ankle-brachial index in hypertensive patients?
Absolute Event Rate: 9.6% vs 16.8%
p-value: p=<0.001
Asymptomatic PAD is highly prevalent (14.4%) among hypertensive patients, highlighting the potential utility of ABI screening for cardiovascular risk stratification.
May support ABI screening in hypertension; leaves open whether BP control causally reduces PAD.
AIMS: Peripheral arterial disease (PAD) can be diagnosed in asymptomatic stage, measuring ankle-brachial index (ABI). Low ABI is an indicator of increased cardiovascular risk and its inclusion to traditional risk factors can improve risk prediction. The objective of the present cross-sectional part of our large-scale, multicenter, observational study was to evaluate the prevalence of PAD in a large cohort of hypertensive patients. METHODS AND RESULTS: A total of 21 892 hypertensive men and women (9162 men; mean age 61.45 years) were included in our prospective study in hypertension clinics. Clinical history, physical examination, and blood analysis were taken, and the ABI was measured with the Doppler method in all patients. The prevalence of PAD (ABI ≤ 0.9) was 14.4%. In 15.6% of the patients an ABI of 0.91-0.99, and in 9.4% of the patients high ABI (>1.3) was measured. In the low, moderate, high, and very high Systematic Coronary Risk Evaluation risk groups, the prevalence of low ABI was 8.1, 11.1, 16.3, and 26%, respectively. The prevalence of PAD was lower in hypertensive patients achieving their blood pressure target (9.6 vs. 16.8%; P < 0.001). CONCLUSIONS: Asymptomatic PAD was highly prevalent in the studied hypertensive population. The use of ABI screening may improve cardiovascular risk prediction. Optimal blood pressure goal values in PAD patients and cardiovascular morbidity/mortality data will be evaluated after the 5-year long prospective phase of the Evaluation of Ankle-Brachial Index in Hungarian Hypertensives program.
No takes yet. Share an insight, caveat, or question.
Farkas et al. (2012) conducted a cross-sectional in Hypertension (n=21,892). Achieving blood pressure target vs. Not achieving blood pressure target was evaluated on Prevalence of peripheral arterial disease (ABI ≤ 0.9) (p=<0.001). The prevalence of peripheral arterial disease in hypertensive patients was 14.4%, and was significantly lower in those achieving their blood pressure target (9.6% vs. 16.8%; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: